2 Biotech Stocks Wall Street Predicts Will Double By StockNews
© Reuters. 2 Biotech Stocks Wall Street Predicts Will Double
Biotechnology is advancing rapidly, driven by robust investments in new developments and a demand for synthetic biology. The industry is expected to continue to generate significant growth over an extended period. Therefore, Wall Street analysts expect Tarsus (TARS) and Cidara (CDTX) to deliver more than 100% upside. So, are you sure you don’t want to read on for details?.The biotech industry is advancing rapidly with significant breakthroughs in research and technological improvements. The industry is expected to continue playing a major role in addressing the resurgent COVID-19 pandemic.
Supportive government initiatives and robust funding are clearing a path to the industry’s continued growth. And, according to a new report by Grand View Research, Inc., the industry is expected to expand at a 15.83% CAGR over the next seven years.
Given the industry’s strong growth prospects, Wall Street analysts expect biotech stocks Tarsus Pharmaceuticals, Inc. (TARS) and Cidara Therapeutics, Inc. (NASDAQ:) to more than double in price in the near term.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
